IQVIA narrows annual profit forecast amid continued research contract cancellations

Core Viewpoint - IQVIA Holdings has narrowed its annual profit forecast, reducing the upper end of its outlook due to expected ongoing cancellations of research contracts from pharmaceutical clients [1] Company Summary - The company anticipates that the trend of contract cancellations will continue into the future, impacting its financial performance [1] Industry Summary - The pharmaceutical industry is facing challenges that are leading to a reduction in research contracts, which may affect companies like IQVIA Holdings that rely on these contracts for revenue [1]